Related Experiment Video
Updated: Jan 24, 2026
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
A four-stage strategy to reduce childhood pneumonia-related mortality by 2015 and beyond
Insights
Pneumonia in children under 5 is a major concern. Evaluating both pneumococcal and influenza vaccines, alongside new diagnostics and interventions, is crucial for reducing pneumonia burden globally.
Area of Science:
- Pediatrics
- Vaccinology
- Infectious Diseases
Background:
- Pneumonia remains a leading cause of mortality in children under 5 globally.
- Pneumococcal vaccines are established interventions, but the role of influenza vaccines in reducing childhood pneumonia requires further investigation.
- Current research gaps exist in understanding the full impact of influenza vaccination on early childhood pneumonia.
Discussion:
- The study highlights the need for integrated strategies to combat childhood pneumonia.
- Evaluating the combined impact of pneumococcal and influenza vaccines is essential.
- Controlled trials in tropical and sub-tropical regions of Asia and Africa are recommended.
Key Insights:
- Influenza vaccine's effect on early childhood pneumonia is underexplored.
- A comprehensive approach including diagnostics and intervention research is necessary.
- Vaccine impact evaluation should be prioritized in high-burden regions.
Outlook:
- Future research should focus on controlled trials to assess vaccine efficacy.
- Developing new diagnostics and understanding pneumonia mortality pathways are critical.
- Integrated strategies are key to reducing pneumonia morbidity and mortality in young children.
Abstract:
The global community has considered several vaccines to reduce pneumonia morbidity and mortality among children <5 years. Recent burden estimates support pneumococcal vaccine introduction, however, influenza vaccine has received only recent attention. The effect of influenza vaccine on early childhood pneumonia has not been adequately explored. As part of an integrated four-stage strategy, both pneumococcal and influenza vaccine impact on pneumonia burden reduction should be evaluated in controlled trials in tropical and sub-tropical Asian and African countries, along with evaluation of new aetiology diagnostics, research into common pneumonia mortality pathways and interventions targeting those pathways.
More Related Videos
08:09Psychophysiological Assessment of the Effectiveness of Emotion Regulation Strategies in Childhood
Published on: February 11, 2017
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
01:18Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....